Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | Rho-associated, coiled-coil containing protein kinase 2 | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | hypothetical protein | 0.0191 | 0.3362 | 0.3362 |
Brugia malayi | PAS domain containing protein | 0.0057 | 0.0846 | 0.0846 |
Onchocerca volvulus | Eukaryotic initiation factor 4A homolog | 0.0212 | 0.3752 | 0.7694 |
Brugia malayi | Cytochrome P450 family protein | 0.0014 | 0.0048 | 0.0048 |
Schistosoma mansoni | single-minded | 0.0057 | 0.0846 | 0.2255 |
Loa Loa (eye worm) | CYP4Cod1 | 0.0014 | 0.0048 | 0.0048 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0014 | 0.0048 | 0.0048 |
Mycobacterium leprae | Possible regulatory protein | 0.0015 | 0.0056 | 0.5 |
Schistosoma mansoni | DEAD box ATP-dependent RNA helicase | 0.0212 | 0.3752 | 1 |
Loa Loa (eye worm) | hypoxia-induced factor 1 | 0.0177 | 0.3084 | 0.3084 |
Mycobacterium ulcerans | putative regulatory protein | 0.0042 | 0.0569 | 1 |
Onchocerca volvulus | 0.0015 | 0.0056 | 0.0114 | |
Leishmania major | protein kinase, putative | 0.0015 | 0.0063 | 0.0039 |
Trypanosoma cruzi | STE/STE11 serine/threonine-protein kinase, putative | 0.0015 | 0.0063 | 0.0039 |
Toxoplasma gondii | eukaryotic initiation factor-4A, putative | 0.0212 | 0.3752 | 0.5 |
Treponema pallidum | ATP-dependent RNA helicase | 0.0212 | 0.3752 | 0.5 |
Onchocerca volvulus | 0.0042 | 0.0569 | 0.1166 | |
Loa Loa (eye worm) | hypothetical protein | 0.0191 | 0.3362 | 0.3362 |
Trypanosoma cruzi | Eukaryotic initiation factor 4A-1 | 0.0212 | 0.3752 | 1 |
Chlamydia trachomatis | two component regulatory system sensor histidine kinase | 0.0015 | 0.0056 | 0.5 |
Loa Loa (eye worm) | pax transcription factor protein 2 | 0.0272 | 0.4876 | 0.4876 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0176 | 0.3068 | 0.8178 |
Echinococcus granulosus | aryl hydrocarbon receptor | 0.0015 | 0.0056 | 0.0148 |
Brugia malayi | Cytochrome P450 family protein | 0.0014 | 0.0048 | 0.0048 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0212 | 0.3752 | 1 |
Echinococcus multilocularis | eukaryotic initiation factor 4A | 0.0212 | 0.3752 | 1 |
Echinococcus multilocularis | rho associated protein kinase | 0.0176 | 0.3068 | 0.8178 |
Trypanosoma cruzi | PAS-domain containing phosphoglycerate kinase, putative | 0.0015 | 0.0056 | 0.002 |
Mycobacterium tuberculosis | Probable cold-shock DeaD-box protein A homolog DeaD (ATP-dependent RNA helicase dead homolog) | 0.0212 | 0.3752 | 0.5 |
Echinococcus granulosus | single minded 2 | 0.0042 | 0.0569 | 0.1516 |
Entamoeba histolytica | DEAD/DEAH box helicase, putative | 0.0212 | 0.3752 | 0.5 |
Plasmodium falciparum | eukaryotic initiation factor 4A | 0.0212 | 0.3752 | 0.5 |
Brugia malayi | hypoxia-induced factor 1 | 0.0177 | 0.3084 | 0.3084 |
Echinococcus granulosus | Aryl hydrocarbon receptor nuclear | 0.0015 | 0.0056 | 0.0148 |
Leishmania major | eukaryotic initiation factor 4a, putative | 0.0212 | 0.3752 | 1 |
Schistosoma mansoni | aryl hydrocarbon receptor | 0.0057 | 0.0846 | 0.2255 |
Brugia malayi | bHLH-PAS transcription factor | 0.0042 | 0.0569 | 0.0569 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0212 | 0.3752 | 1 |
Giardia lamblia | Translation initiation factor eIF-4A, putative | 0.0212 | 0.3752 | 0.5 |
Trypanosoma brucei | Eukaryotic initiation factor 4A-1 | 0.0212 | 0.3752 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0014 | 0.0048 | 0.0048 |
Leishmania major | protein kinase, putative | 0.0015 | 0.0063 | 0.0039 |
Echinococcus multilocularis | eukaryotic initiation factor 4A III | 0.0212 | 0.3752 | 1 |
Trichomonas vaginalis | DEAD box ATP-dependent RNA helicase, putative | 0.0212 | 0.3752 | 1 |
Echinococcus granulosus | eukaryotic initiation factor 4A III | 0.0212 | 0.3752 | 1 |
Trypanosoma cruzi | STE group serine/threonine-protein kinase, putative | 0.0015 | 0.0063 | 0.0039 |
Trypanosoma cruzi | STE/STE11 serine/threonine-protein kinase, putative | 0.0015 | 0.0063 | 0.0039 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.0056 | 0.0056 |
Echinococcus multilocularis | aryl hydrocarbon receptor | 0.0015 | 0.0056 | 0.0148 |
Trypanosoma cruzi | STE group serine/threonine-protein kinase, putative | 0.0015 | 0.0063 | 0.0039 |
Echinococcus granulosus | eukaryotic initiation factor 4A | 0.0212 | 0.3752 | 1 |
Echinococcus multilocularis | transfer RNA-Lys | 0.0042 | 0.0569 | 0.1516 |
Loa Loa (eye worm) | hypothetical protein | 0.0212 | 0.3752 | 0.3752 |
Trypanosoma cruzi | Eukaryotic initiation factor 4A-1 | 0.0212 | 0.3752 | 1 |
Echinococcus granulosus | rho-associated protein kinase 1 | 0.0176 | 0.3068 | 0.8178 |
Onchocerca volvulus | 0.0272 | 0.4876 | 1 | |
Onchocerca volvulus | 0.0175 | 0.3061 | 0.6278 | |
Loa Loa (eye worm) | aryl Hydrocarbon receptor Associated protein family member | 0.0015 | 0.0056 | 0.0056 |
Echinococcus multilocularis | Aryl hydrocarbon receptor nuclear | 0.0015 | 0.0056 | 0.0148 |
Leishmania major | eukaryotic initiation factor 4a, putative | 0.0212 | 0.3752 | 1 |
Brugia malayi | Pax transcription factor protein 2 | 0.0272 | 0.4876 | 0.4876 |
Brugia malayi | eukaryotic initiation factor 4A | 0.0212 | 0.3752 | 0.3752 |
Onchocerca volvulus | 0.0176 | 0.3068 | 0.6293 | |
Schistosoma mansoni | DEAD box ATP-dependent RNA helicase | 0.0212 | 0.3752 | 1 |
Leishmania major | PAS-domain containing phosphoglycerate kinase, putative | 0.0015 | 0.0056 | 0.002 |
Plasmodium vivax | RNA helicase-1, putative | 0.0212 | 0.3752 | 0.5 |
Trypanosoma cruzi | PAS-domain containing phosphoglycerate kinase, putative | 0.0015 | 0.0056 | 0.002 |
Loa Loa (eye worm) | AGC/DMPK/ROCK protein kinase | 0.0546 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.